Bharat Biotech recalls a batch of ChiroRaba vaccine on account of theft

BL Hyderabad Bureau Updated - January 26, 2023 at 09:59 AM.

Bharat Biotech’s arm Chiron Behring Vaccines has voluntarily recalled a batch of ChiroRaba vaccine.

“We have issued a voluntary product recall of a specific batch of Chiroraba with batch number 4188. This action was initiated due to the theft of Chiroraba from the shipping services provider in Karnataka,’‘ the Hyderabad-based vaccine maker said in a statement. 

In accordance with company and regulatory requirements, batch 4188 was fully tested and released. While only part of the shipment was stolen, for which cold chain storage conditions are unknown, the action to recall the entire batch has been initiated, it said. 

“The company requests that batch 4188 not be sold and returned to the company. Healthcare providers are requested not to administer Chiroraba with batch 4188,” the statement said. 

The voluntary action was in accordance with the principle of abundant precaution, keeping patient safety and the public interest in mind, it added.

Published on January 24, 2023 05:38

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

TheHindu Businessline operates by its editorial values to provide you quality journalism.

This is your last free article.